On December 1, 2022 Infant rhesus macaques immunized against SARS-CoV-2 are protected against heterologous virus challenge one year later
On November 2, 2022 A self-amplifying RNA vaccine against COVID-19 with long-term room-termperature stability
On July 15, 2022 Heterologous saRNA Prime, DNA Dual-Antigen Boost SARS-CoV-2 Vaccination Elicits Robust Cellular Immunogenicity and Cross-Variant Neutralizing Antibodies
On November 18, 2021 Development of COVID-19 vaccine using a dual Toll-like receptor ligand liposome adjuvant
